These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 21135372)

  • 1. Mutation type is not clinically useful in predicting prognosis in hypertrophic cardiomyopathy.
    Landstrom AP; Ackerman MJ
    Circulation; 2010 Dec; 122(23):2441-9; discussion 2450. PubMed ID: 21135372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ascertainment strategies and genotype:phenotype correlations in hypertrophic cardiomyopathy.
    Blair E; Redwood C; Watkins H
    Circulation; 2003 Jul; 108(4):e24-5; author reply e24-5. PubMed ID: 12885737
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetics of hypertrophic cardiomyopathy: what is the next step?
    Kuusisto J
    Heart; 2020 Sep; 106(17):1291-1292. PubMed ID: 32546508
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of the Mayo Clinic Phenotype-Based Genotype Predictor Score in Patients with Clinically Diagnosed Hypertrophic Cardiomyopathy.
    Murphy SL; Anderson JH; Kapplinger JD; Kruisselbrink TM; Gersh BJ; Ommen SR; Ackerman MJ; Bos JM
    J Cardiovasc Transl Res; 2016 Apr; 9(2):153-61. PubMed ID: 26914223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal hypertrophic cardiomyopathy caused by double mutation in RAS pathway genes.
    Pervunina T; Vershinina T; Kiselev A; Nikitina I; Grekhov E; Mitrofanova L; Sjoberg G; Kostareva A
    Int J Cardiol; 2015 Apr; 184():272-273. PubMed ID: 25731833
    [No Abstract]   [Full Text] [Related]  

  • 6. Adverse clinical course and poor prognosis of hypertrophic cardiomyopathy due to mutations in FHL1.
    Gallego-Delgado M; Gonzalez-Lopez E; Garcia-Guereta L; Ortega-Molina M; Gonzalez-Vioque E; Cobo-Marcos M; Alonso-Pulpon L; Garcia-Pavia P
    Int J Cardiol; 2015 Jul; 191():194-7. PubMed ID: 25965631
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic factors in familial hypertrophic cardiomyopathy: does molecular cardiology offer new perspectives?
    Komajda M
    Heart; 1996 Dec; 76(6):465-6. PubMed ID: 9014791
    [No Abstract]   [Full Text] [Related]  

  • 8. Myocardial Deformation Analysis in
    Höller V; Seebacher H; Zach D; Schwegel N; Ablasser K; Kolesnik E; Gollmer J; Waltl G; Rainer PP; Verheyen S; Zirlik A; Verheyen N
    Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertrophic Cardiomyopathy Attributable to Mitochondrial DNA Mutation Diagnosed by Pathology and Gene Sequencing.
    Choi Y; Lee JH; Cui MN; Lee YS; Jung MH; Yi JE; Jung HO; Youn HJ
    Circulation; 2016 Mar; 133(13):1297-9. PubMed ID: 27022042
    [No Abstract]   [Full Text] [Related]  

  • 10. [Genetic tests in hypertrophic cardiomyopathy: Benefits, limitations, and applications in clinical practice].
    Gómez Arraiz I; Barrio Ollero E; Gómez Peligros A
    Semergen; 2018 Oct; 44(7):485-491. PubMed ID: 29858109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypertrophic cardiomyopathy: never-ending complexity].
    Navarro-López F
    Rev Esp Cardiol; 2006 Oct; 59(10):994-6. PubMed ID: 17125707
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiac magnetic resonance in hypertrophic cardiomyopathy.
    To AC; Dhillon A; Desai MY
    JACC Cardiovasc Imaging; 2011 Oct; 4(10):1123-37. PubMed ID: 21999873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with familial hypertrophic cardiomyopathy caused by a Phe110Ile missense mutation in the cardiac troponin T gene have variable cardiac morphologies and a favorable prognosis.
    Anan R; Shono H; Kisanuki A; Arima S; Nakao S; Tanaka H
    Circulation; 1998 Aug; 98(5):391-7. PubMed ID: 9714088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of Genetic Testing in Hypertrophic Cardiomyopathy: an Analysis Using Real-World Data.
    Alejandra Restrepo-Cordoba M; Campuzano O; Ripoll-Vera T; Cobo-Marcos M; Mademont-Soler I; Gámez JM; Dominguez F; Gonzalez-Lopez E; Padron-Barthe L; Lara-Pezzi E; Alonso-Pulpon L; Brugada R; Garcia-Pavia P
    J Cardiovasc Transl Res; 2017 Feb; 10(1):35-46. PubMed ID: 28138913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in understanding hypertrophic cardiomyopathy.
    Mohiddin S; Fananapazir L
    Hosp Pract (1995); 2001 May; 36(5):23-5, 29-30, 33-6. PubMed ID: 11361156
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and genetic characteristics of alpha cardiac actin gene mutations in hypertrophic cardiomyopathy.
    Mogensen J; Perrot A; Andersen PS; Havndrup O; Klausen IC; Christiansen M; Bross P; Egeblad H; Bundgaard H; Osterziel KJ; Haltern G; Lapp H; Reinecke P; Gregersen N; Børglum AD
    J Med Genet; 2004 Jan; 41(1):e10. PubMed ID: 14729850
    [No Abstract]   [Full Text] [Related]  

  • 17. The Gln1233ter mutation of the myosin binding protein C gene: causative mutation or innocent polymorphism in patients with hypertrophic cardiomyopathy?
    Tóth T; Nagy V; Faludi R; Csanády M; Nemes A; Simor T; Forster T; Sepp R
    Int J Cardiol; 2011 Dec; 153(2):216-9. PubMed ID: 21985754
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of DNA testing for diagnosis, management, and genetic screening in long QT syndrome, hypertrophic cardiomyopathy, and Marfan syndrome.
    Vincent GM
    Heart; 2001 Jul; 86(1):12-4. PubMed ID: 11410552
    [No Abstract]   [Full Text] [Related]  

  • 19. Mutations in cis can confound genotype-phenotype correlations in hypertrophic cardiomyopathy.
    Blair E; Price SJ; Baty CJ; Ostman-Smith I; Watkins H
    J Med Genet; 2001 Jun; 38(6):385-8. PubMed ID: 11424919
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical challenges of genotype positive (+)-phenotype negative (-) family members in hypertrophic cardiomyopathy.
    Maron BJ; Yeates L; Semsarian C
    Am J Cardiol; 2011 Feb; 107(4):604-8. PubMed ID: 21185001
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.